These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20573265)

  • 1. Sigma-1 receptor agonist fluvoxamine for postoperative delirium in older adults: report of three cases.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2010 Jun; 9():28. PubMed ID: 20573265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sigma-1 receptor agonist fluvoxamine for delirium in intensive care units: report of five cases.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2010 Apr; 9():18. PubMed ID: 20416097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sigma-1 receptor agonist fluvoxamine for delirium in patients with Alzheimer's disease.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2010 Jan; 9():6. PubMed ID: 20148109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptors.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2010 Mar; 9():11. PubMed ID: 20205742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluvoxamine for blonanserin-associated akathisia in patients with schizophrenia: report of five cases.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2010 Apr; 9():17. PubMed ID: 20416096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The opposite effects of fluvoxamine and sertraline in the treatment of psychotic major depression: a case report.
    Kishimoto A; Todani A; Miura J; Kitagaki T; Hashimoto K
    Ann Gen Psychiatry; 2010 May; 9():23. PubMed ID: 20492642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvoxamine monotherapy for psychotic depression: the potential role of sigma-1 receptors.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2009 Dec; 8():26. PubMed ID: 20025739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Report of Rabbit Syndrome Who Benefited from Sigma 1 Agonist Fluvoxamine.
    Albayrak Y; Beyazyüz M; Abbak Ö; Altındağ E
    Clin Psychopharmacol Neurosci; 2019 Feb; 17(1):134-138. PubMed ID: 30690950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can the sigma-1 receptor agonist fluvoxamine prevent schizophrenia?
    Hashimoto K
    CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):470-4. PubMed ID: 19702566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug therapy for delirium in terminally ill adults.
    Finucane AM; Jones L; Leurent B; Sampson EL; Stone P; Tookman A; Candy B
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004770. PubMed ID: 31960954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersalivation induced by olanzapine with fluvoxamine.
    Hori T; Makabe K; Nemoto K; Asada T
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):758-60. PubMed ID: 16574294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluvoxamine treatment of obsessive-compulsive symptoms in schizophrenic patients: an add-on open study.
    Poyurovsky M; Isakov V; Hromnikov S; Modai I; Rauchberger B; Schneidman M; Weizman A
    Int Clin Psychopharmacol; 1999 Mar; 14(2):95-100. PubMed ID: 10220124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obsessive and compulsive symptoms in schizophrenia: a randomized controlled trial with fluvoxamine and neuroleptics.
    Reznik I; Sirota P
    J Clin Psychopharmacol; 2000 Aug; 20(4):410-6. PubMed ID: 10917401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
    Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K
    Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sedative Load in Community-Dwelling Older Adults with Mild-Moderate Alzheimer's Disease: Longitudinal Relationships with Adverse Events, Delirium and Falls.
    Dyer AH; Murphy C; Lawlor B; Kennelly SP;
    Drugs Aging; 2020 Nov; 37(11):829-837. PubMed ID: 32924095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of local anesthetic injection in geriatric patients following operative management of proximal and diaphyseal femur fracture.
    Fisher BM; Titus AJ; Gitajn IL
    Injury; 2019 Nov; 50(11):2055-2059. PubMed ID: 31564373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of recent clinical trials and guidelines on the prevention and management of delirium in hospitalized older patients.
    Rathier MO; Baker WL
    Hosp Pract (1995); 2011 Oct; 39(4):96-106. PubMed ID: 22056829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects.
    Boettger S; Jenewein J; Breitbart W
    Palliat Support Care; 2015 Aug; 13(4):1079-85. PubMed ID: 25191793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postoperative cognitive dysfunction of older surgical patients].
    Damuleviciene G; Lesauskaite V; Macijauskiene J
    Medicina (Kaunas); 2010; 46(3):169-75. PubMed ID: 20516755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.